Frontlight ResearchEarly access
Lung cancer trials in South Korea
170 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleStudy to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
- Where
- Goyang-si, Seongnam-si, Seoul
- Age
- 18 years and over
- People
- 51
- Run by
- Oscotec Inc.
See details and how to joinNCT07358806 - No phaseNot yet taking people in South KoreaAssociation of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study
- Where
- Seoul
- Age
- 19 years and over
- People
- 60
- Run by
- Seoul National University Hospital
See details and how to joinNCT07331701 - Phase 2Taking peopleBolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)
- Where
- Busan
- Age
- 20 years and over
- People
- 70
- Run by
- Pusan National University Hospital
See details and how to joinNCT07073365 - No phaseTaking peopleObservational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection
- Where
- Seoul
- Age
- 19 years and over
- People
- 300
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06021483 - No phaseTaking peopleSWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
- Where
- Seongnam-si
- Age
- 40 years and over
- People
- 100
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT07102589 - Phase 1/2Taking peopleFIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
- Where
- Seoul
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06669117 · EU 2024-512760-64-00 - No phaseNot yet taking people in South KoreaEffect of Bilateral vs. Unilateral Alveolar Recruitment on Gas Exchange in Lung Resection
- Where
- Seoul
- Age
- 20 years to 80 years
- People
- 198
- Run by
- Yonsei University
See details and how to joinNCT07044661 - No phaseTaking peopleDiagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
- Where
- Seoul
- Age
- 19 years and over
- People
- 1,200
- Run by
- Yonsei University
See details and how to joinNCT07035587 - No phaseTaking peopleA Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
- Where
- Seoul
- Age
- 21 years to 99 years
- People
- 600 worldwide
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT06418412 - Phase 1/2Taking peopleA Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
- Where
- Cheongju-si, Goyang-si, Seoul, Suwon
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- J Ints Bio
See details and how to joinNCT05394831 - Phase 1Not yet taking people in South KoreaEvaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC
- Where
- Seoul
- Age
- 19 years and over
- People
- 18
- Run by
- GeneCraft Inc.
See details and how to joinNCT06934590 - No phaseTaking peopleA Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females
- Where
- Seoul
- Age
- 45 years to 74 years
- People
- 200
- Run by
- Sang-Won Um
See details and how to joinNCT06181929 - No phaseEnrolling by invitationCryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions
- Where
- Busan, Daegu, Daejeon
- Age
- 18 years and over
- People
- 200
- Run by
- Pusan National University Hospital
See details and how to joinNCT06752395 - No phaseTaking peopleProspective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
- Where
- Daegu, Gyeonggi-do, Hwasun, Ilsan, Jinju, Seongnam-si, Seoul, Yangsan
- Age
- 19 years and over
- People
- 1,240
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT05804786 - No phaseNot yet taking people in South KoreaEffects of Cognitive Intervention Therapy on Postoperative Delirium
- Where
- Seoul
- Age
- 65 years and over
- People
- 60
- Run by
- Yonsei University
See details and how to joinNCT06178939 - Phase 2Taking peopleA Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
- Where
- Goyang-si, Seoul, Suwon
- Age
- 19 years and over
- People
- 120
- Run by
- National Cancer Center, Korea
See details and how to joinNCT06156527 - Phase 2Taking peopleAnti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Where
- Anam, Anyang, Hwasun, Seoul, Yangsan
- Age
- 19 years to 80 years
- People
- 60
- Run by
- CrystalGenomics, Inc.
See details and how to joinNCT05841472 - Phase 2Taking peopleNeoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy
- Where
- Seoul
- Age
- 19 years and over
- People
- 40
- Run by
- Konkuk University Medical Center
See details and how to joinNCT05469022 - No phaseTaking peopleCell Free DNA for the Diagnosis and Treatment in Early NSCLC
- Where
- Seoul
- Age
- 18 years to 90 years
- People
- 700
- Run by
- Samsung Medical Center
See details and how to joinNCT03791034 - No phaseTaking peopleControls for Respiratory Diseases
- Where
- Seoul
- Age
- 19 years to 90 years
- People
- 1,572
- Run by
- Seoul National University Hospital
See details and how to joinNCT03120481